Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |